$2.09 0.02 (+0.97%)
11/25/2009 3:59 PM

Corcept Therapeutics, Inc. (CORT)

CAPS Rating: 2 out of 5

A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.

Featured Broker Partners